Evidence map›Paper›PMID 10456874›Full record

ArticleInfection and immunity1999

Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model.

J Katz, K P Black, S M Michalek

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 76 citations in OpenAlex.

  1. Vaccines · 2024
    Review
  2. Development of semisynthetic saponin immunostimulants.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2024
    Review
  3. Review
  4. Review
  5. Structural Effect on Adjuvanticity of Saponins.Journal of medicinal chemistry · 2020
    Article
  6. Vaccine Adjuvants Derivatized fromJournal of medicinal chemistry · 2019
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Gene therapy in periodontics.Journal of Indian Society of Periodontology · 2013
    Article
  12. Article
  13. Article
  14. Novel and often bizarre strategies in the treatment of periodontal disease.Journal of Indian Society of Periodontology · 2012
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J KatzDepartment of Oral Biology, School of Dentistry, The University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. jenny_katz@micro.microbio.uab.edu
K P Black
S M Michalek
University of Alabama at Birmingham · US

Funding

REGULATION OF IMMUNE RESPONSES IN THE ORAL CAVITYR01DE008182 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MICHALEK, SUZANNE M. · 1988 to 2003
$972k
THREE NOVEL PROTEINS OF THE EXTRACELLULAR MATRIXP50DE008228 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BAKER, JOHN · 1988 to 1999
–
MICROBIAL/HOST IMMUNE REGULATION IN PERIODONTAL DISEASER29DE010607 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KATZ, JANNET · 1994 to 1998
–
NIDCR NIH HHS DE 08182NIDCR NIH HHS DE 08228NIDCR NIH HHS DE 10607NIDCR NIH HHS R01 DE008182
6 · The paper itself

Abstract

Porphyromonas gingivalis, a gram-negative, black-pigmented anaerobe, is among the microorganisms implicated in the etiology of adult periodontal disease. This bacterium possesses a number of factors, including hemagglutinins, of potential importance in virulence. Several hemagglutinin genes have been identified, cloned, and expressed in Escherichia coli. The purpose of this study was to characterize host responses to purified recombinant hemagglutinin B (rHag B), using the conventional Fischer rat as the experimental animal model. The effectiveness of immunization with rHag B on protection against experimental periodontal bone loss following infection with P. gingivalis was also evaluated. Groups of rats were immunized by the subcutaneous route with rHag B in complete Freund's adjuvant, immunized with rHag B and orally infected with P. gingivalis, nonimmunized and noninfected, or orally infected with P. gingivalis only. Serum and saliva samples were collected throughout the experiment and evaluated for serum immunoglobulin G (IgG) and IgM and salivary IgA antibody activity by enzyme-linked immunosorbent assay. No salivary IgA anti-Hag B activity was detected in the various groups of rats. A slight serum IgM response similar to that seen in preimmune samples was observed. Serum IgG antibody activity to Hag B was detected only in samples from rats immunized with rHag B. This response was primarily of the IgG1 and IgG2a subclasses, followed by IgG2b and low levels of IgG2c. Supernatants from rHag B-stimulated splenic lymphoid cell cultures from immunized rats contained high levels of gamma interferon, followed by interleukin-2 (IL-2), IL-10, and then IL-4. These results are consistent with the induction of T helper type 1 (Th1)- and Th2-like responses. Western blot analysis of sera derived from rHag B-immunized rats reacted with trichloroacetic acid (TCA) precipitates of P. gingivalis 33277, 381, A7A1-28, and W50, revealing a 50-kDa band reflective of Hag B. However, sera derived from rats immunized with P. gingivalis whole cells or from rats infected with P. gingivalis only did not react with rHag B but did react with TCA precipitates of P. gingivalis strains. Finally, radiographic measurements of periodontal bone loss indicated that rats immunized with rHag B had less bone loss than those infected with P. gingivalis only. These results demonstrate the effectiveness of purified rHag B in inducing a protective immune response and support the potential usefulness of this component of P. gingivalis in the development of a vaccine against adult periodontitis.

Indexed as

Adhesins, BacterialAlveolar Bone LossAnimalsAntibodies, BacterialBacterial ProteinsBacterial VaccinesBacteroidaceae InfectionsBlotting, WesternCell DivisionCells, CulturedCytokinesDisease Models, AnimalHemagglutininsLectinsMandiblePorphyromonas gingivalisAdhesins, BacterialAntibodies, BacterialBacterial ProteinsBacterial VaccinesCytokinesHagB protein, Porphyromonas gingivalisHemagglutininsLectinsRecombinant Fusion ProteinsVaccines, Synthetic

Identifiers

PMID10456874
PMCPMC96752
OpenAlexW1861428035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.